ADHS und komorbide Suchterkrankungen
Book Item (Buchkapitel, Lexikonartikel, jur. Kommentierung, Beiträge in Sammelbänden)
 
ID 4523090
Author(s) Stadler, Christina; Hofecker Fallahpour, Maria; Stieglitz, Rolf-Dieter
Author(s) at UniBasel Stieglitz, Rolf Dieter
Year 2019
Title ADHS und komorbide Suchterkrankungen
Editor(s) Walter, Marc; Gouzoulis-Mafrank, Euphrosyne
Book title Psychische Störungen und Suchterkrankungen
Edition 2. Aufl.
Publisher Kohlhammer
Place of publication Stuttgart
Pages 150-168
ISSN/ISBN 978-3-17-035049-6 ; 978-3-17-035052-6
Abstract BACKGROUND: ADHD in childhood and adolescence is characterized by the symptoms hyperactivity, impulsivity, and inattentiveness; these symptoms may persist into adulthood or may manifest as restlessness, emotional instability, and disorganized behavior. In adults ADHD often occurs with increased substance use and is associated with an early onset of substance use, development of severe addiction, and decreased treatment effectiveness.METHOD: This overview will present and critically discuss current study results and evidence-based and consensus-oriented recommendations that ensure the most adequate care for patients with ADHD and addictive disorder.RESULTS AND CONCLUSIONS: For drug therapy, the current S3 guideline recommends methylphenidate, amphetamine salts, and atomoxetine, among others. Treatment of adult patients with ADHD and addiction with stimulants tends to be viewed critically; if required, long-acting medications should be used. Integrated treatment of ADHD and addiction, consisting of a combination of pharmacotherapy and psychotherapy, is recommended.
edoc-URL https://edoc.unibas.ch/77070/
Full Text on edoc No
Digital Object Identifier DOI 10.1007/s15006-019-0740-0
ISI-number MEDLINE:31313269
 
   

MCSS v5.8 PRO. 0.451 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
10/08/2020